The Patent Finder

Allergan Therapeutics LLC

6 patents currently held · Updated Nov 18, 2026
12 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Jul 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 15, 2027
    The maintenance fee for Graduated estrogen contraceptive (US 9,132,137) comes due Mar 15, 2027. Unpaid by Sep 15, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 6 of 6

PatentTitleStatus Expires Confidence
US 7,795,241Derivative Prodrugs of Ethinyl Estradiol
In force
 · High confidence
In forceHigh confidence
US 9,132,137Graduated estrogen contraceptive
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,461,138Quadraphasis Continuous Graduated Estrogen Contraceptive
In force
 · High confidence
In forceHigh confidence
US 9,795,569Pharmaceutical soft gelatin capsule dosage form with modified guar gum
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,744,096Pharmaceutical soft gelatin capsule dosage form with modified guar gum
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,820,946Pharmaceutical soft gelatin capsule dosage form with modified guar gum
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 6: 12 patents in force now held by others · 2 lapsed for an unpaid fee · 6 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited